Vertex Pharmaceuticals Incorporated company logo
Vertex Pharmaceuticals Incorporated logo

VRTX EBITDA

Annual EBITDA

$4.97B$402.80M+8.82%

Summary

Current Value
As of today, VRTX annual EBITDA is $4.97B, up +8.82% on
Historical Performance
VRTX annual EBITDA is up +17.48% over the past 3 years, up +66.56% over the past 5 years
All-Time High Comparison
VRTX annual EBITDA is currently at its all-time high
3-Year Low Comparison
VRTX annual EBITDA is +17.48% above its 3-year low of $4.23B reached on an earlier date
Sector Comparison
VRTX annual EBITDA is higher than 97.69% of companies in Healthcare sector

EBITDA Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

VRTX Performance
MetricDateValue1Y3Y5Y15Y
Annual EBITDA$4.97B+8.8%+17.5%+66.6%+848.0%
Quarterly EBITDA$1.35B+19.5%+29.2%+71.9%+942.3%
TTM EBITDA$4.95B+10000.0%+16.6%+65.9%+845.1%
Price$493.50+4.0%+71.7%+132.2%+1000.6%
PE Ratio32.18+43.5%+55.8%
Annual Revenue$12.07B+9.9%+38.0%+94.5%+8322.0%
Annual EPS$15.32+837.8%+19.5%+48.8%+506.4%
Annual EBIT$4.69B+7.5%+14.9%+63.1%+774.9%
Annual Net Income$3.95B+838.1%+19.0%+45.8%+623.9%

EBITDA Highs

VRTX Annual EBITDA Highs Comparison
PeriodHighDateCurrent
3Y$4.97Bat high
5Y$4.97Bat high
All$4.97Bat high

EBITDA Lows

VRTX Annual EBITDA Lows Comparison
PeriodLowDateCurrent
3Y$4.23BN/A+17.5%
5Y$2.93B+69.3%
All-$664.12M+848.0%

EBITDA History

YearValueChange
$4.97B+8.8%
$4.57B+2.4%
$4.46B+5.4%
$4.23B+44.1%
$2.93B-1.6%
$2.98B+133.7%
$1.28B+73.0%
$737.64M+60.6%
$459.33M+532.7%
$72.60M+118.0%
-$402.33M+30.4%
-$578.23M-282.8%
-$151.06M-456.6%
$42.37M-83.5%
$256.74M+138.7%
-$664.12M-18.0%
-$562.67M-32.0%
-$426.19M-10.6%
YearValueChange
-$385.21M-93.1%
-$199.52M-74.3%
-$114.45M-6.4%
-$107.59M+27.9%
-$149.27M-58.5%
-$94.17M-87.6%
-$50.19M-69.6%
-$29.59M+33.5%
-$44.47M-2.9%
-$43.23M-46.3%
-$29.54M-10.9%
-$26.64M-16.9%
-$22.79M-32.2%
-$17.25M-438.2%
$5.10M+170.4%
-$7.24M-92.8%
-$3.76M+8.4%
-$4.10M-

FAQ

  • What is the current annual EBITDA of VRTX?

    As of today, VRTX annual EBITDA is $4.97B

  • What is 1-year change in VRTX annual EBITDA?

    VRTX annual EBITDA is up +8.82% year-over-year

  • What is 3-year change in VRTX annual EBITDA?

    VRTX annual EBITDA is up +17.48% over the past 3 years

  • How far is VRTX annual EBITDA from its all-time high?

    VRTX annual EBITDA is currently at its all-time high

  • How does VRTX annual EBITDA rank versus sector peers?

    VRTX annual EBITDA is higher than 97.69% of companies in Healthcare sector

  • When is VRTX next annual earnings release?

    As of today, the next annual earnings release for VRTX has not been scheduled

EBITDA Formula

Data Sources & References

  1. VRTX Official Website www.vrtx.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/875320/000087532026000056/0000875320-26-000056-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/875320/000087532026000056/0000875320-26-000056-index.htm
  4. VRTX Profile on Yahoo Finance finance.yahoo.com/quote/VRTX
  5. VRTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrtx